HighTower Advisors »

Perspective Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4M 141k 9.97

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Perspective Therapeutics

Henderson Group
BlackRock
BlackRock
Avidity Partners Management
Commodore Capital
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Marshall Wace
Octagon Capital Advisors
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors

View all funds holding Perspective Therapeutics